Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity: A Single-Center, Double-Blind, Placebo-Controlled, Flexible-Dose Study in Outpatients.
Phase of Trial: Phase III
Latest Information Update: 21 Jun 2011
At a glance
- Drugs Lamotrigine (Primary)
- Indications Binge-eating disorder
- Focus Therapeutic Use
- 01 May 2009 Results have been published in International Clinical Psychopharmacology.
- 24 Feb 2009 Additional trial centre added as reported by ClinicalTrials.gov, last updated 13 Feb 09.
- 13 Feb 2009 End date added from ClinicalTrials.gov.